Vote Scores
Filings read through

How funds voted at Amicus Therapeutics, Inc.

Filers reporting
384, year to 30 June 2026
Latest meeting on file
Meetings on file
3

In the year to 30 June 2026, 384 filers on Form N-PX reported votes at Amicus Therapeutics, Inc.. The votes fall in 2 meetings. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 568 marks to the ballot items, each with or against management. 90.0% of the marks are with management.

On say-on-pay, 43 of the 358 reporting filers that marked the item voted against management. This is 12.0% of the filers. Of the reported shares, 10.3% went against management. The median of the 3,799 companies on this site with a say-on-pay item is 6.6% of filers and 2.9% of reported shares.

At the meeting of 3 Mar 2026, 40 fund families have a say-on-pay position with management and 5 have a position against management.

By filers reporting in the year to 30 June 2026, Amicus Therapeutics, Inc. was number 1,590 of 11,972 companies with a page and votes in that year. The number of filers reporting at Amicus Therapeutics, Inc. did not change from the year to 30 June 2025 to the year to 30 June 2026. At the companies on this site with filers in both years, the total of filers reporting rose by 6.0%. In all seasons on file, category SECTION 14A SAY-ON-PAY VOTES is 33.8% of the vote records at Amicus Therapeutics, Inc.. At all companies on this site, it is 12.3%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 3 Mar 2026

382 filers reported votes at this meeting in the year to 30 June 2026. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Advisory vote on executive pay (say-on-pay)

    526 vote records from 374 filers. 43 of the 358 filers that marked the item voted against management. 16 filers gave no management mark.

    • Positions of 45 fund families
    • For 40
    • Against 5
    • Against management 5
  2. Item 2: Advisory vote on pay tied to a merger or sale

    8 vote records from 7 filers. 4 of the 7 filers that marked the item voted against management.

    • Positions of one fund family
    • Against 1
    • Against management 1
  3. Item 3: EXTRAORDINARY TRANSACTIONS: management items

    The company's items in this category are shown together, because filers word and number them differently.

    180 vote records from 92 filers. 0 of the 92 filers that marked the item voted against management.

    • Positions of 36 fund families
    • For 36
  4. Item 4: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    220 vote records from 108 filers. 10 of the 108 filers that marked the item voted against management.

    • Positions of 37 fund families
    • For 33
    • Against 4
    • Against management 4
  5. Item 5: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    1 vote record from 1 filer. 0 of the 1 filer that marked the item voted against management.

Positions of the fund families at the meeting of 3 Mar 2026

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Amicus Therapeutics, Inc., meeting of 3 Mar 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familySay-on-payMerger pay
AllianceBernsteinAgainst, against managementNo report
AllspringForNo report
American BeaconForNo report
American CenturyAgainst, against managementNo report
BairdForNo report
BlackRock and iSharesForNo report
BNY MellonForNo report
Brighthouse FundsForNo report
Charles SchwabForNo report
Columbia ThreadneedleForNo report
DimensionalForNo report
DWSForNo report
EquitableForNo report
Federated HermesForNo report
FidelityForNo report
First TrustForNo report
Franklin TempletonForNo report
Global XForNo report
Goldman SachsForNo report
Guggenheim and RydexForNo report
InvescoForNo report
J.P. MorganNo reportAgainst, against management
Janus HendersonForNo report
John Hancock and ManulifeForNo report
Lincoln FinancialForNo report
Macquarie and Delaware FundsForNo report
MassMutualForNo report
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementNo report
NationwideForNo report
Natixis and Loomis SaylesForNo report
Neuberger BermanForNo report
Northern Trust and FlexSharesForNo report
Nuveen and TIAAAgainst, against managementNo report
Pacific Life fundsForNo report
PGIM and PrudentialForNo report
PIMCOForNo report
PrincipalForNo report
ProShares and ProFundsForNo report
Russell InvestmentsForNo report
SEIForNo report
State Street and SPDRForNo report
T. Rowe PriceForNo report
VanguardForNo report
Victory CapitalForNo report
VoyaAgainst, against managementNo report
WisdomTreeForNo report

Every meeting on file

Meetings of Amicus Therapeutics, Inc., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2026382512.0%
year to 30 June 202538246.7%
year to 30 June 202437046.2%

Say-on-pay, season by season

Say-on-pay at Amicus Therapeutics, Inc.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202638412.0%10.3%
year to 30 June 20253846.7%0.8%
year to 30 June 20243726.2%2.1%
Amicus Therapeutics, Inc. and the median of companies on this site, year to 30 June 2026
Say-on-payThis companyMedian of companies on this site
Filers against management12.0%6.6%
Reported shares against management10.3%2.9%

The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Amicus Therapeutics, Inc. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS1,76836.7%
SECTION 14A SAY-ON-PAY VOTES1,63133.8%
AUDIT-RELATED50710.5%
EXTRAORDINARY TRANSACTIONS1803.7%
COMPENSATION51210.6%
CORPORATE GOVERNANCE2214.6%

The record at the SEC

Each link loaded on .

Embed this card on your site

Copy this code into your page. The card shows the figures above with their source. A line under the card links to this page.

How embedding works. It is free. Keep the link in the card and the link line under it.

Cite this page

Vote Scores. How funds voted at Amicus Therapeutics, Inc.. https://votescores.com/company/amicus-therapeutics-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Amicus Therapeutics, Inc. are on file?
3 meetings are on file, from 6 Jun 2024 to 3 Mar 2026. 3 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at Amicus Therapeutics, Inc.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2026. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Amicus Therapeutics, Inc. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Amicus Therapeutics, Inc., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .